Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 21,303 | 7,632 | 27,376 | 23,529 | 29,455 |
| Gross Profit | 21,303 | 7,632 | 27,376 | 23,529 | 29,455 |
| Operating Expenses | 45,357 | 57,752 | 43,322 | 45,769 | 34,308 |
| Operating Income | -24,054 | -50,120 | -15,946 | -22,240 | -4,853 |
| Other Income | 3,322 | 1,689 | 2,335 | 2,404 | 2,180 |
| Pre-tax Income | -20,732 | -48,431 | -13,611 | -19,836 | -2,673 |
| Net Income Continuous | -20,732 | -48,433 | -13,611 | -19,836 | -2,673 |
| Net Income | $-20,732 | $-48,433 | $-13,611 | $-19,836 | $-2,673 |
| EPS Basic Total Ops | -0.20 | -0.48 | -0.13 | -0.20 | -0.03 |
| EPS Basic Continuous Ops | -0.20 | -0.48 | -0.13 | -0.20 | -0.03 |
| EPS Diluted Total Ops | -0.20 | -0.48 | -0.13 | -0.20 | -0.03 |
| EPS Diluted Continuous Ops | -0.20 | -0.48 | -0.13 | -0.20 | -0.03 |
| EBITDA(a) | $-22,508 | $-48,474 | $-14,176 | $-20,626 | $-3,416 |